Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 6.66277639 |
2 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.42850354 |
3 | regulation of gamma-delta T cell activation (GO:0046643) | 6.07591754 |
4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.07308198 |
5 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 5.52168385 |
6 | NIK/NF-kappaB signaling (GO:0038061) | 5.13993225 |
7 | positive thymic T cell selection (GO:0045059) | 5.10787966 |
8 | endothelial cell chemotaxis (GO:0035767) | 4.94528751 |
9 | myeloid dendritic cell differentiation (GO:0043011) | 4.91580881 |
10 | response to peptidoglycan (GO:0032494) | 4.83182723 |
11 | myeloid dendritic cell activation (GO:0001773) | 4.62103960 |
12 | negative thymic T cell selection (GO:0045060) | 4.58218502 |
13 | negative T cell selection (GO:0043383) | 4.55115084 |
14 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.37564861 |
15 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.33896001 |
16 | positive T cell selection (GO:0043368) | 4.27974024 |
17 | tolerance induction (GO:0002507) | 4.21082460 |
18 | positive regulation of isotype switching (GO:0045830) | 4.20634368 |
19 | negative regulation of cell killing (GO:0031342) | 4.20357222 |
20 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.20357222 |
21 | response to muramyl dipeptide (GO:0032495) | 4.18575996 |
22 | interferon-gamma production (GO:0032609) | 4.17320864 |
23 | positive regulation of interleukin-2 production (GO:0032743) | 4.07144072 |
24 | thymic T cell selection (GO:0045061) | 4.06393415 |
25 | macrophage activation involved in immune response (GO:0002281) | 4.05776074 |
26 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.02956665 |
27 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.02956665 |
28 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.01923521 |
29 | positive regulation of B cell mediated immunity (GO:0002714) | 3.99795271 |
30 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.99795271 |
31 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.99141706 |
32 | response to interleukin-15 (GO:0070672) | 3.98407604 |
33 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.97444813 |
34 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.96676464 |
35 | leukocyte aggregation (GO:0070486) | 3.93104372 |
36 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.86596232 |
37 | positive regulation of humoral immune response (GO:0002922) | 3.86017480 |
38 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.82771957 |
39 | regulation of regulatory T cell differentiation (GO:0045589) | 3.81091272 |
40 | T cell selection (GO:0045058) | 3.77997793 |
41 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.77683866 |
42 | regulation of immunoglobulin secretion (GO:0051023) | 3.76399532 |
43 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.72442859 |
44 | defense response to protozoan (GO:0042832) | 3.68411667 |
45 | cellular response to interleukin-15 (GO:0071350) | 3.66879793 |
46 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.63984233 |
47 | neutrophil activation involved in immune response (GO:0002283) | 3.62257271 |
48 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.59236721 |
49 | positive regulation of DNA recombination (GO:0045911) | 3.56934577 |
50 | positive regulation of B cell differentiation (GO:0045579) | 3.54386434 |
51 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.50240474 |
52 | T-helper 1 type immune response (GO:0042088) | 3.47706402 |
53 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.46023640 |
54 | T cell migration (GO:0072678) | 3.44911335 |
55 | cellular extravasation (GO:0045123) | 3.42723997 |
56 | response to protozoan (GO:0001562) | 3.41890308 |
57 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.41100675 |
58 | dendritic cell differentiation (GO:0097028) | 3.37129508 |
59 | regulation of T cell tolerance induction (GO:0002664) | 3.36519816 |
60 | regulation of chemokine biosynthetic process (GO:0045073) | 3.34585239 |
61 | regulation of B cell differentiation (GO:0045577) | 3.32665981 |
62 | positive regulation of interleukin-12 production (GO:0032735) | 3.30689192 |
63 | regulation of chronic inflammatory response (GO:0002676) | 3.30594297 |
64 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.28528822 |
65 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.27876536 |
66 | T cell receptor signaling pathway (GO:0050852) | 3.24578700 |
67 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.24536531 |
68 | regulation of B cell mediated immunity (GO:0002712) | 3.21689721 |
69 | B cell receptor signaling pathway (GO:0050853) | 3.21628523 |
70 | regulation of interleukin-2 production (GO:0032663) | 3.21453714 |
71 | negative regulation of T cell mediated immunity (GO:0002710) | 3.21171068 |
72 | mature B cell differentiation (GO:0002335) | 3.19859251 |
73 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.19232374 |
74 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.18500899 |
75 | regulation of interleukin-12 production (GO:0032655) | 3.15170269 |
76 | regulation of isotype switching (GO:0045191) | 3.15036822 |
77 | positive regulation of antigen processing and presentation (GO:0002579) | 3.14823272 |
78 | negative regulation of interleukin-12 production (GO:0032695) | 3.14591199 |
79 | regulation of interferon-alpha production (GO:0032647) | 3.14156494 |
80 | myeloid cell activation involved in immune response (GO:0002275) | 3.13588317 |
81 | positive regulation of interleukin-10 production (GO:0032733) | 3.13573843 |
82 | regulation of antigen processing and presentation (GO:0002577) | 3.11779930 |
83 | B cell mediated immunity (GO:0019724) | 3.10817214 |
84 | granulocyte activation (GO:0036230) | 3.10378361 |
85 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.09953431 |
86 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.09534491 |
87 | cellular response to nicotine (GO:0071316) | 3.08050117 |
88 | positive regulation of T cell cytokine production (GO:0002726) | 3.05554555 |
89 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.05383614 |
90 | microglial cell activation (GO:0001774) | 3.03926892 |
91 | positive regulation of interferon-alpha production (GO:0032727) | 3.03885978 |
92 | detection of other organism (GO:0098543) | 3.03662286 |
93 | regulation of response to interferon-gamma (GO:0060330) | 3.03407248 |
94 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.03157398 |
95 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.02524048 |
96 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.01732586 |
97 | germinal center formation (GO:0002467) | 3.01323190 |
98 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.00743628 |
99 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.00006854 |
100 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.00006854 |
101 | modulation by symbiont of host immune response (GO:0052553) | 3.00006854 |
102 | positive regulation by symbiont of host defense response (GO:0052509) | 3.00006854 |
103 | modulation by symbiont of host defense response (GO:0052031) | 3.00006854 |
104 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.00006854 |
105 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.99412641 |
106 | regulation of vitamin metabolic process (GO:0030656) | 2.98775922 |
107 | positive regulation of immunoglobulin production (GO:0002639) | 2.98334309 |
108 | activated T cell proliferation (GO:0050798) | 2.97822329 |
109 | regulation of immunoglobulin production (GO:0002637) | 2.95873349 |
110 | response to type I interferon (GO:0034340) | 2.95803472 |
111 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.95156577 |
112 | detection of bacterium (GO:0016045) | 2.94773294 |
113 | cellular response to type I interferon (GO:0071357) | 2.94632270 |
114 | type I interferon signaling pathway (GO:0060337) | 2.94632270 |
115 | macrophage activation (GO:0042116) | 2.94549427 |
116 | immunoglobulin mediated immune response (GO:0016064) | 2.94372221 |
117 | positive regulation of T cell differentiation (GO:0045582) | 2.94033163 |
118 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.93911251 |
119 | T cell costimulation (GO:0031295) | 2.93868592 |
120 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.93414678 |
121 | positive regulation of heat generation (GO:0031652) | 2.93004951 |
122 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 2.92854350 |
123 | T cell lineage commitment (GO:0002360) | 2.89196862 |
124 | positive regulation of interleukin-17 production (GO:0032740) | 2.89171743 |
125 | lymphocyte costimulation (GO:0031294) | 2.88668363 |
126 | neutrophil activation (GO:0042119) | 2.88648878 |
127 | leukocyte cell-cell adhesion (GO:0007159) | 2.88508350 |
128 | positive regulation of B cell proliferation (GO:0030890) | 2.86981064 |
129 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.86806888 |
130 | response to xenobiotic stimulus (GO:0009410) | 2.86644434 |
131 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.86337644 |
132 | T cell homeostasis (GO:0043029) | 2.84894244 |
133 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.84239600 |
134 | natural killer cell activation (GO:0030101) | 2.82955452 |
135 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.82720591 |
136 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.81836927 |
137 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.81797894 |
138 | regulation of growth of symbiont in host (GO:0044126) | 2.81797894 |
139 | negative regulation of growth of symbiont in host (GO:0044130) | 2.81797894 |
140 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.81797894 |
141 | positive regulation of interferon-beta production (GO:0032728) | 2.81775101 |
142 | positive regulation of B cell activation (GO:0050871) | 2.80724641 |
143 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.80085284 |
144 | regulation of germinal center formation (GO:0002634) | 2.79950194 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.87910297 |
2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.69632716 |
3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.56651226 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.51791131 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.83233896 |
6 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.82563678 |
7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.52985053 |
8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.48178423 |
9 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 3.34565612 |
10 | MYC_22102868_ChIP-Seq_BL_Human | 3.30147766 |
11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.18897481 |
12 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.14474767 |
13 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.11029998 |
14 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.10653724 |
15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.05428319 |
16 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.05221181 |
17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.86369191 |
18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.81959380 |
19 | MYB_26560356_Chip-Seq_TH2_Human | 2.79324036 |
20 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.75420233 |
21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.71095410 |
22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.70292936 |
23 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.66980628 |
24 | MAF_26560356_Chip-Seq_TH1_Human | 2.57027823 |
25 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.49061368 |
26 | MYB_26560356_Chip-Seq_TH1_Human | 2.39194017 |
27 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.32777362 |
28 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.19517023 |
29 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.15677900 |
30 | UTX_26944678_Chip-Seq_JUKART_Human | 2.08458666 |
31 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.03832456 |
32 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.97770353 |
33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.96509879 |
34 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.95421032 |
35 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.92992497 |
36 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.90012622 |
37 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.89628198 |
38 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83582167 |
39 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.77022312 |
40 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.76088301 |
41 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.74553727 |
42 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.74364721 |
43 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.72115604 |
44 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.71921716 |
45 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.65327460 |
46 | MAF_26560356_Chip-Seq_TH2_Human | 1.64729466 |
47 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.63773631 |
48 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.53039627 |
49 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.49422637 |
50 | SPI1_23127762_ChIP-Seq_K562_Human | 1.46822243 |
51 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.45723192 |
52 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.45024049 |
53 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40051372 |
54 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.39695729 |
55 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.31955857 |
56 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22257359 |
57 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.20833338 |
58 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.20635329 |
59 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.19346924 |
60 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19276478 |
61 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18548352 |
62 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14967112 |
63 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.14813313 |
64 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.14437771 |
65 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.14349454 |
66 | GATA3_26560356_Chip-Seq_TH2_Human | 1.13368293 |
67 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11593397 |
68 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11573978 |
69 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.10767193 |
70 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08963457 |
71 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07303176 |
72 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.07111936 |
73 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.06855326 |
74 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.04451108 |
75 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.03000858 |
76 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02434186 |
77 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00970115 |
78 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.00263312 |
79 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99887865 |
80 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.98033438 |
81 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94049435 |
82 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.92089679 |
83 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.88954240 |
84 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.88318530 |
85 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88021345 |
86 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.87891559 |
87 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87316123 |
88 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87198766 |
89 | P300_27268052_Chip-Seq_Bcells_Human | 0.86926461 |
90 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.86386240 |
91 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.85739914 |
92 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.85661766 |
93 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.85296490 |
94 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.84833599 |
95 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.84487311 |
96 | GATA1_22025678_ChIP-Seq_K562_Human | 0.84055731 |
97 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.80288360 |
98 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80145772 |
99 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78609836 |
100 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.77178367 |
101 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.76015557 |
102 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.75511329 |
103 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.73991488 |
104 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.73971060 |
105 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72410704 |
106 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.71334005 |
107 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.69818387 |
108 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.67757530 |
109 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.67450361 |
110 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.67313926 |
111 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.66885389 |
112 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.66652558 |
113 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.66377413 |
114 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.66041758 |
115 | GATA1_19941826_ChIP-Seq_K562_Human | 0.64777359 |
116 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.64625044 |
117 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.64466856 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.14334520 |
2 | MP0000685_abnormal_immune_system | 3.67883621 |
3 | MP0003436_decreased_susceptibility_to | 3.57023151 |
4 | MP0005671_abnormal_response_to | 3.45612699 |
5 | MP0003303_peritoneal_inflammation | 3.37808793 |
6 | MP0004510_myositis | 3.35239331 |
7 | * MP0003763_abnormal_thymus_physiology | 3.25489656 |
8 | MP0001800_abnormal_humoral_immune | 3.20103618 |
9 | MP0005000_abnormal_immune_tolerance | 3.19524928 |
10 | MP0001790_abnormal_immune_system | 3.19289255 |
11 | MP0005387_immune_system_phenotype | 3.19289255 |
12 | MP0009785_altered_susceptibility_to | 2.81433935 |
13 | MP0001853_heart_inflammation | 2.77026448 |
14 | MP0002452_abnormal_antigen_presenting | 2.76344603 |
15 | * MP0002723_abnormal_immune_serum | 2.75324828 |
16 | MP0003300_gastrointestinal_ulcer | 2.71869293 |
17 | MP0002405_respiratory_system_inflammati | 2.68225564 |
18 | * MP0002420_abnormal_adaptive_immunity | 2.53680560 |
19 | MP0002148_abnormal_hypersensitivity_rea | 2.52971327 |
20 | * MP0001819_abnormal_immune_cell | 2.52276216 |
21 | MP0005025_abnormal_response_to | 2.48699647 |
22 | MP0002419_abnormal_innate_immunity | 2.39602827 |
23 | MP0002166_altered_tumor_susceptibility | 2.34614320 |
24 | MP0003724_increased_susceptibility_to | 2.31381786 |
25 | * MP0002398_abnormal_bone_marrow | 2.31159064 |
26 | MP0006082_CNS_inflammation | 2.22129532 |
27 | MP0004947_skin_inflammation | 2.15805826 |
28 | * MP0000716_abnormal_immune_system | 2.09771871 |
29 | MP0009333_abnormal_splenocyte_physiolog | 2.06682972 |
30 | MP0001873_stomach_inflammation | 2.04540471 |
31 | MP0002006_tumorigenesis | 2.01073821 |
32 | MP0000689_abnormal_spleen_morphology | 1.94556814 |
33 | MP0002138_abnormal_hepatobiliary_system | 1.93377936 |
34 | * MP0010155_abnormal_intestine_physiology | 1.88693205 |
35 | MP0002396_abnormal_hematopoietic_system | 1.87932305 |
36 | MP0004808_abnormal_hematopoietic_stem | 1.86916560 |
37 | MP0002722_abnormal_immune_system | 1.86015811 |
38 | MP0003866_abnormal_defecation | 1.85002768 |
39 | MP0000703_abnormal_thymus_morphology | 1.83075377 |
40 | * MP0001845_abnormal_inflammatory_respons | 1.72590400 |
41 | * MP0002429_abnormal_blood_cell | 1.70283241 |
42 | MP0005464_abnormal_platelet_physiology | 1.67106525 |
43 | MP0001533_abnormal_skeleton_physiology | 1.61827843 |
44 | MP0000465_gastrointestinal_hemorrhage | 1.56395452 |
45 | MP0009278_abnormal_bone_marrow | 1.52971628 |
46 | MP0005310_abnormal_salivary_gland | 1.48515377 |
47 | MP0008057_abnormal_DNA_replication | 1.46577275 |
48 | MP0002933_joint_inflammation | 1.38823256 |
49 | MP0001851_eye_inflammation | 1.33864922 |
50 | MP0005397_hematopoietic_system_phenotyp | 1.32149870 |
51 | MP0001545_abnormal_hematopoietic_system | 1.32149870 |
52 | MP0000604_amyloidosis | 1.29043835 |
53 | MP0003448_altered_tumor_morphology | 1.22712841 |
54 | MP0008961_abnormal_basal_metabolism | 1.22358497 |
55 | MP0002998_abnormal_bone_remodeling | 1.20976538 |
56 | MP0008469_abnormal_protein_level | 1.16814318 |
57 | MP0003195_calcinosis | 1.15065446 |
58 | MP0002254_reproductive_system_inflammat | 1.12805144 |
59 | MP0000858_altered_metastatic_potential | 1.12770653 |
60 | MP0005167_abnormal_blood-brain_barrier | 1.12553518 |
61 | MP0010352_gastrointestinal_tract_polyps | 1.06627178 |
62 | MP0003806_abnormal_nucleotide_metabolis | 1.05743156 |
63 | MP0010307_abnormal_tumor_latency | 1.04457246 |
64 | MP0005076_abnormal_cell_differentiation | 1.02753027 |
65 | MP0005423_abnormal_somatic_nervous | 1.02578887 |
66 | MP0009764_decreased_sensitivity_to | 0.95800245 |
67 | MP0002139_abnormal_hepatobiliary_system | 0.92903840 |
68 | MP0005451_abnormal_body_composition | 0.92899052 |
69 | MP0000490_abnormal_crypts_of | 0.92096650 |
70 | MP0003453_abnormal_keratinocyte_physiol | 0.90127155 |
71 | MP0005058_abnormal_lysosome_morphology | 0.84493136 |
72 | MP0002019_abnormal_tumor_incidence | 0.82385203 |
73 | MP0002693_abnormal_pancreas_physiology | 0.81094930 |
74 | MP0005174_abnormal_tail_pigmentation | 0.80549747 |
75 | MP0000015_abnormal_ear_pigmentation | 0.80342907 |
76 | MP0003172_abnormal_lysosome_physiology | 0.80160030 |
77 | MP0000569_abnormal_digit_pigmentation | 0.79741911 |
78 | MP0005390_skeleton_phenotype | 0.77406088 |
79 | MP0002277_abnormal_respiratory_mucosa | 0.77215585 |
80 | MP0008004_abnormal_stomach_pH | 0.76252990 |
81 | MP0005166_decreased_susceptibility_to | 0.75642994 |
82 | MP0003191_abnormal_cellular_cholesterol | 0.73976077 |
83 | MP0003075_altered_response_to | 0.72716255 |
84 | MP0003656_abnormal_erythrocyte_physiolo | 0.71993978 |
85 | MP0003795_abnormal_bone_structure | 0.71803132 |
86 | MP0003045_fibrosis | 0.69074177 |
87 | MP0001501_abnormal_sleep_pattern | 0.69009739 |
88 | MP0004782_abnormal_surfactant_physiolog | 0.68303794 |
89 | MP0008007_abnormal_cellular_replicative | 0.68036383 |
90 | MP0000249_abnormal_blood_vessel | 0.67682857 |
91 | MP0001348_abnormal_lacrimal_gland | 0.67557016 |
92 | MP0004742_abnormal_vestibular_system | 0.66885118 |
93 | MP0009763_increased_sensitivity_to | 0.64913174 |
94 | MP0003183_abnormal_peptide_metabolism | 0.64223119 |
95 | MP0001986_abnormal_taste_sensitivity | 0.63714326 |
96 | MP0005075_abnormal_melanosome_morpholog | 0.63488965 |
97 | MP0009840_abnormal_foam_cell | 0.62873768 |
98 | MP0003828_pulmonary_edema | 0.62478003 |
99 | MP0001663_abnormal_digestive_system | 0.62363851 |
100 | MP0002009_preneoplasia | 0.61790209 |
101 | MP0000609_abnormal_liver_physiology | 0.61526854 |
102 | MP0002132_abnormal_respiratory_system | 0.61218865 |
103 | MP0008260_abnormal_autophagy | 0.59603654 |
104 | MP0003091_abnormal_cell_migration | 0.58442300 |
105 | MP0002332_abnormal_exercise_endurance | 0.56203436 |
106 | MP0002136_abnormal_kidney_physiology | 0.56034269 |
107 | MP0000343_altered_response_to | 0.55755169 |
108 | MP0009765_abnormal_xenobiotic_induced | 0.54557513 |
109 | MP0004381_abnormal_hair_follicle | 0.54339758 |
110 | MP0000371_diluted_coat_color | 0.53977081 |
111 | MP0005647_abnormal_sex_gland | 0.53736876 |
112 | MP0001216_abnormal_epidermal_layer | 0.53685091 |
113 | MP0005535_abnormal_body_temperature | 0.53594904 |
114 | MP0005023_abnormal_wound_healing | 0.53316743 |
115 | MP0001243_abnormal_dermal_layer | 0.52973882 |
116 | MP0001881_abnormal_mammary_gland | 0.52919859 |
117 | MP0003077_abnormal_cell_cycle | 0.51867151 |
118 | MP0000367_abnormal_coat/_hair | 0.49176201 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Stomatitis (HP:0010280) | 7.52297225 |
2 | Eczematoid dermatitis (HP:0000976) | 6.12133958 |
3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.76080592 |
4 | Recurrent fungal infections (HP:0002841) | 4.75590739 |
5 | Recurrent abscess formation (HP:0002722) | 4.68996171 |
6 | Mediastinal lymphadenopathy (HP:0100721) | 4.50426875 |
7 | Recurrent bacterial skin infections (HP:0005406) | 4.32995844 |
8 | T lymphocytopenia (HP:0005403) | 4.14389768 |
9 | Recurrent viral infections (HP:0004429) | 4.13019813 |
10 | Myositis (HP:0100614) | 4.12409052 |
11 | Abnormality of T cell number (HP:0011839) | 4.10729041 |
12 | Panhypogammaglobulinemia (HP:0003139) | 3.92499987 |
13 | Severe combined immunodeficiency (HP:0004430) | 3.92442514 |
14 | Increased IgM level (HP:0003496) | 3.86752548 |
15 | Abnormality of glycolipid metabolism (HP:0010969) | 3.84930625 |
16 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.84930625 |
17 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.84930625 |
18 | Optic neuritis (HP:0100653) | 3.67883561 |
19 | Retrobulbar optic neuritis (HP:0100654) | 3.67883561 |
20 | Abnormality of T cells (HP:0002843) | 3.63643996 |
21 | IgM deficiency (HP:0002850) | 3.62570474 |
22 | Combined immunodeficiency (HP:0005387) | 3.53878547 |
23 | Vasculitis (HP:0002633) | 3.53061519 |
24 | Orchitis (HP:0100796) | 3.52890396 |
25 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.50054408 |
26 | Recurrent cutaneous fungal infections (HP:0011370) | 3.50054408 |
27 | IgG deficiency (HP:0004315) | 3.46016675 |
28 | B lymphocytopenia (HP:0010976) | 3.39437710 |
29 | Abnormality of B cell number (HP:0010975) | 3.39437710 |
30 | Recurrent bronchitis (HP:0002837) | 3.39129935 |
31 | Pulmonary infiltrates (HP:0002113) | 3.37194985 |
32 | Increased cerebral lipofuscin (HP:0011813) | 3.33598951 |
33 | IgA deficiency (HP:0002720) | 3.29014320 |
34 | Recurrent skin infections (HP:0001581) | 3.26616649 |
35 | Leukocytosis (HP:0001974) | 3.20905688 |
36 | Chronic diarrhea (HP:0002028) | 3.19931057 |
37 | Vacuolated lymphocytes (HP:0001922) | 3.19746073 |
38 | Chronic otitis media (HP:0000389) | 3.17523943 |
39 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.13692245 |
40 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.12689908 |
41 | Gingivitis (HP:0000230) | 3.11352006 |
42 | Abnormality of T cell physiology (HP:0011840) | 3.10946830 |
43 | Gastrointestinal infarctions (HP:0005244) | 3.09370731 |
44 | Arterial thrombosis (HP:0004420) | 3.08901186 |
45 | Thyroiditis (HP:0100646) | 3.02767950 |
46 | Nasal polyposis (HP:0100582) | 3.02348420 |
47 | Thrombocytosis (HP:0001894) | 3.01873775 |
48 | Increased density of long bones (HP:0006392) | 3.01318371 |
49 | Abnormality of the fingertips (HP:0001211) | 2.97334790 |
50 | Obstructive lung disease (HP:0006536) | 2.95824807 |
51 | Chronic obstructive pulmonary disease (HP:0006510) | 2.95824807 |
52 | Autoimmune thrombocytopenia (HP:0001973) | 2.93368871 |
53 | Eosinophilia (HP:0001880) | 2.91802814 |
54 | Meningitis (HP:0001287) | 2.88984847 |
55 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.87936355 |
56 | Persistence of primary teeth (HP:0006335) | 2.85349192 |
57 | Abnormality of eosinophils (HP:0001879) | 2.85072025 |
58 | Lymphopenia (HP:0001888) | 2.84888248 |
59 | Pustule (HP:0200039) | 2.81398215 |
60 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.80190438 |
61 | Inflammation of the large intestine (HP:0002037) | 2.80143764 |
62 | Dysostosis multiplex (HP:0000943) | 2.79694753 |
63 | Autoimmune hemolytic anemia (HP:0001890) | 2.74257340 |
64 | Gastrointestinal stroma tumor (HP:0100723) | 2.73662370 |
65 | Abnormality of macrophages (HP:0004311) | 2.72536799 |
66 | Polyneuropathy (HP:0001271) | 2.71121317 |
67 | Colitis (HP:0002583) | 2.68290280 |
68 | Gastrointestinal inflammation (HP:0004386) | 2.65355112 |
69 | Agammaglobulinemia (HP:0004432) | 2.63980028 |
70 | Hemoptysis (HP:0002105) | 2.60752075 |
71 | Cellulitis (HP:0100658) | 2.60052626 |
72 | Increased IgE level (HP:0003212) | 2.60026710 |
73 | Abnormality of the nasal mucosa (HP:0000433) | 2.58808931 |
74 | Gangrene (HP:0100758) | 2.58607511 |
75 | Urticaria (HP:0001025) | 2.56396316 |
76 | Hypergammaglobulinemia (HP:0010702) | 2.52475381 |
77 | Granulocytopenia (HP:0001913) | 2.50357525 |
78 | Spontaneous hematomas (HP:0007420) | 2.50250074 |
79 | Lymphoma (HP:0002665) | 2.49622015 |
80 | Chest pain (HP:0100749) | 2.48639082 |
81 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.48459206 |
82 | Recurrent sinusitis (HP:0011108) | 2.45235882 |
83 | Loss of speech (HP:0002371) | 2.44750149 |
84 | Periodontitis (HP:0000704) | 2.41797145 |
85 | Fatigue (HP:0012378) | 2.41603900 |
86 | Abnormality of the pleura (HP:0002103) | 2.37348353 |
87 | Keratoconjunctivitis sicca (HP:0001097) | 2.36759820 |
88 | Myocardial infarction (HP:0001658) | 2.35312330 |
89 | Interstitial pulmonary disease (HP:0006530) | 2.33338051 |
90 | Abnormality of the prostate (HP:0008775) | 2.31646909 |
91 | Emphysema (HP:0002097) | 2.26444275 |
92 | Osteomyelitis (HP:0002754) | 2.25469543 |
93 | Gingival bleeding (HP:0000225) | 2.25419877 |
94 | Joint swelling (HP:0001386) | 2.25344674 |
95 | Increased serum ferritin (HP:0003281) | 2.23623643 |
96 | Disinhibition (HP:0000734) | 2.23245574 |
97 | Keratoconjunctivitis (HP:0001096) | 2.19134121 |
98 | Amaurosis fugax (HP:0100576) | 2.19055061 |
99 | Amyloidosis (HP:0011034) | 2.15588754 |
100 | Anorexia (HP:0002039) | 2.14425360 |
101 | Encephalitis (HP:0002383) | 2.12895885 |
102 | Epistaxis (HP:0000421) | 2.12872673 |
103 | Mutism (HP:0002300) | 2.10482549 |
104 | Peripheral hypomyelination (HP:0007182) | 2.10286701 |
105 | Acute myeloid leukemia (HP:0004808) | 2.10025741 |
106 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.09919994 |
107 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.09434018 |
108 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.09434018 |
109 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.09434018 |
110 | Episodic fever (HP:0001954) | 2.09425648 |
111 | Sepsis (HP:0100806) | 2.07627438 |
112 | Hematochezia (HP:0002573) | 2.06004381 |
113 | Recurrent pneumonia (HP:0006532) | 2.04517414 |
114 | Restrictive lung disease (HP:0002091) | 2.02362022 |
115 | Alveolar cell carcinoma (HP:0006519) | 2.01502598 |
116 | Somatic mutation (HP:0001428) | 2.00838818 |
117 | Prolonged bleeding time (HP:0003010) | 1.91937968 |
118 | Arthralgia (HP:0002829) | 1.89845148 |
119 | Upper limb muscle weakness (HP:0003484) | 1.87302335 |
120 | Hepatitis (HP:0012115) | 1.87130186 |
121 | Skin ulcer (HP:0200042) | 1.86845818 |
122 | Petechiae (HP:0000967) | 1.86036631 |
123 | Premature loss of primary teeth (HP:0006323) | 1.85350707 |
124 | Systemic lupus erythematosus (HP:0002725) | 1.84639739 |
125 | Pulmonary embolism (HP:0002204) | 1.84550312 |
126 | Leukopenia (HP:0001882) | 1.83486024 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 5.42441441 |
2 | TXK | 4.55695654 |
3 | MAP3K14 | 4.37436378 |
4 | IKBKB | 2.90322073 |
5 | JAK3 | 2.82875327 |
6 | ZAP70 | 2.79998709 |
7 | TBK1 | 2.55313277 |
8 | CHUK | 2.45957659 |
9 | IKBKE | 2.45418891 |
10 | TYK2 | 2.44743037 |
11 | ITK | 2.39686352 |
12 | MAP3K10 | 2.10000221 |
13 | STK10 | 1.90238434 |
14 | IRAK3 | 1.88023508 |
15 | PIM2 | 1.86539461 |
16 | TEC | 1.82303881 |
17 | TNK2 | 1.75859662 |
18 | IRAK4 | 1.72852224 |
19 | TGFBR2 | 1.68192915 |
20 | BTK | 1.65918542 |
21 | JAK1 | 1.62401244 |
22 | PRPF4B | 1.59222747 |
23 | MATK | 1.57256363 |
24 | RIPK4 | 1.57090202 |
25 | MAP3K13 | 1.56040882 |
26 | MAP2K3 | 1.55075172 |
27 | PIM1 | 1.54173063 |
28 | LCK | 1.51203964 |
29 | HCK | 1.50432446 |
30 | CDK12 | 1.49198335 |
31 | RPS6KA4 | 1.48425504 |
32 | GRK6 | 1.46645498 |
33 | EPHB1 | 1.44986755 |
34 | SYK | 1.41532519 |
35 | GRK7 | 1.39842801 |
36 | CSK | 1.39755491 |
37 | BLK | 1.39577554 |
38 | FGFR4 | 1.38335202 |
39 | NLK | 1.33361372 |
40 | TSSK6 | 1.31615866 |
41 | IRAK2 | 1.26800706 |
42 | ACVR1B | 1.22854239 |
43 | FGFR3 | 1.21594279 |
44 | MAP3K11 | 1.20874039 |
45 | KIT | 1.18864493 |
46 | CSF1R | 1.14298695 |
47 | EPHA3 | 1.09284345 |
48 | ADRBK2 | 1.08286644 |
49 | RPS6KA5 | 1.07977324 |
50 | MAP3K3 | 1.03206298 |
51 | JAK2 | 0.99525166 |
52 | TAOK1 | 0.96842224 |
53 | MST4 | 0.96828086 |
54 | CLK1 | 0.92005020 |
55 | EEF2K | 0.91126040 |
56 | CAMKK2 | 0.86903360 |
57 | LYN | 0.86876730 |
58 | MARK3 | 0.86227304 |
59 | TAOK3 | 0.83547662 |
60 | ERN1 | 0.82064594 |
61 | FES | 0.81353285 |
62 | RPS6KA1 | 0.74775744 |
63 | CAMK1D | 0.73540267 |
64 | BRD4 | 0.71985589 |
65 | SIK2 | 0.70436600 |
66 | CDC42BPA | 0.70172046 |
67 | SIK3 | 0.65945679 |
68 | PRKCQ | 0.65090382 |
69 | MAP2K6 | 0.63638849 |
70 | LRRK2 | 0.63445181 |
71 | TAOK2 | 0.60507375 |
72 | NUAK1 | 0.59460975 |
73 | PTK6 | 0.58179946 |
74 | MAPK12 | 0.58002066 |
75 | TLK1 | 0.56702121 |
76 | ALK | 0.56557612 |
77 | DAPK2 | 0.56268090 |
78 | BMPR2 | 0.52807217 |
79 | MAP3K7 | 0.51794271 |
80 | RAF1 | 0.51002926 |
81 | PRKD2 | 0.49154400 |
82 | MAPKAPK2 | 0.48427084 |
83 | PDGFRB | 0.47639428 |
84 | SMG1 | 0.47243854 |
85 | FRK | 0.47207756 |
86 | CDK9 | 0.46103957 |
87 | HIPK2 | 0.45982307 |
88 | MELK | 0.44907251 |
89 | MAP3K1 | 0.44824840 |
90 | GSK3A | 0.43066173 |
91 | IRAK1 | 0.42620961 |
92 | MAP3K8 | 0.42143855 |
93 | TESK2 | 0.40540293 |
94 | ABL1 | 0.40501184 |
95 | PRKCH | 0.40302751 |
96 | MAPK15 | 0.39550420 |
97 | CAMKK1 | 0.38930997 |
98 | EGFR | 0.38217163 |
99 | EIF2AK2 | 0.37326434 |
100 | INSR | 0.35077216 |
101 | MAP3K5 | 0.34744750 |
102 | BCKDK | 0.34658982 |
103 | PDK1 | 0.32996132 |
104 | CDK4 | 0.32700245 |
105 | MARK2 | 0.32110029 |
106 | BMX | 0.32080764 |
107 | RPS6KA6 | 0.31767781 |
108 | TRIB3 | 0.31762088 |
109 | FLT3 | 0.30480346 |
110 | TGFBR1 | 0.30299301 |
111 | MAP2K2 | 0.29283341 |
112 | MAPK7 | 0.29004487 |
113 | MOS | 0.28821235 |
114 | CDK6 | 0.28755583 |
115 | NME2 | 0.28516736 |
116 | RIPK1 | 0.28476890 |
117 | MAPK3 | 0.27259102 |
118 | STK4 | 0.27085256 |
119 | DDR2 | 0.25171805 |
120 | KSR2 | 0.25157526 |
121 | MAPK4 | 0.24612811 |
122 | RPS6KC1 | 0.24511358 |
123 | RPS6KL1 | 0.24511358 |
124 | PRKAA2 | 0.23993536 |
125 | NEK9 | 0.23872439 |
126 | MAPK1 | 0.21882397 |
127 | FYN | 0.21404872 |
128 | KDR | 0.21329248 |
129 | PAK2 | 0.20822299 |
130 | FGR | 0.20155664 |
131 | SIK1 | 0.20098626 |
132 | TRPM7 | 0.19894635 |
133 | ABL2 | 0.18556677 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Allograft rejection_Homo sapiens_hsa05330 | 3.48532767 |
2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.33728646 |
3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.08915157 |
4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.93757151 |
5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.91376472 |
6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.75720484 |
7 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.74073690 |
8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.63788639 |
9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.46948953 |
10 | Measles_Homo sapiens_hsa05162 | 2.39591625 |
11 | Asthma_Homo sapiens_hsa05310 | 2.39422221 |
12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.24091036 |
13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.18490219 |
14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.09210634 |
15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.04805282 |
16 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.97670304 |
17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.95234940 |
18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.86571654 |
19 | Legionellosis_Homo sapiens_hsa05134 | 1.85789627 |
20 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.83600168 |
21 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.81522246 |
22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.77611473 |
23 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.76810461 |
24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.75462291 |
25 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.73229729 |
26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.64753467 |
27 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.51037643 |
28 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.50235578 |
29 | Influenza A_Homo sapiens_hsa05164 | 1.47274394 |
30 | Hepatitis B_Homo sapiens_hsa05161 | 1.45963724 |
31 | Malaria_Homo sapiens_hsa05144 | 1.41764089 |
32 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.41150130 |
33 | Pertussis_Homo sapiens_hsa05133 | 1.40985071 |
34 | Apoptosis_Homo sapiens_hsa04210 | 1.38627241 |
35 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.35569347 |
36 | Tuberculosis_Homo sapiens_hsa05152 | 1.34978408 |
37 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.31888209 |
38 | Shigellosis_Homo sapiens_hsa05131 | 1.24968644 |
39 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.24884817 |
40 | Viral myocarditis_Homo sapiens_hsa05416 | 1.23880723 |
41 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.21866428 |
42 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.16308213 |
43 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.14388798 |
44 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.12873963 |
45 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.11902544 |
46 | Salmonella infection_Homo sapiens_hsa05132 | 1.10175914 |
47 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.09096067 |
48 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.08359995 |
49 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.07215242 |
50 | HTLV-I infection_Homo sapiens_hsa05166 | 1.03287678 |
51 | Hepatitis C_Homo sapiens_hsa05160 | 0.93651543 |
52 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.92401590 |
53 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.91753073 |
54 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.87761868 |
55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.85646386 |
56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82161257 |
57 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.82036206 |
58 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.79778450 |
59 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.73570975 |
60 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.71006671 |
61 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.63064537 |
62 | Platelet activation_Homo sapiens_hsa04611 | 0.61943748 |
63 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.50925616 |
64 | Colorectal cancer_Homo sapiens_hsa05210 | 0.50865086 |
65 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.50549428 |
66 | Amoebiasis_Homo sapiens_hsa05146 | 0.48781452 |
67 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.45101080 |
68 | Insulin resistance_Homo sapiens_hsa04931 | 0.44814213 |
69 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.43641747 |
70 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.43143830 |
71 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.39487489 |
72 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.39286782 |
73 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.38473451 |
74 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.38391563 |
75 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.37004966 |
76 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36814014 |
77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36151464 |
78 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.35468563 |
79 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.35335485 |
80 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.34941974 |
81 | Lysosome_Homo sapiens_hsa04142 | 0.33502083 |
82 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.33177730 |
83 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.32445386 |
84 | Prostate cancer_Homo sapiens_hsa05215 | 0.32161060 |
85 | Other glycan degradation_Homo sapiens_hsa00511 | 0.30814388 |
86 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.30017117 |
87 | Prion diseases_Homo sapiens_hsa05020 | 0.29870598 |
88 | Bladder cancer_Homo sapiens_hsa05219 | 0.29732268 |
89 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.29683198 |
90 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.29618561 |
91 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.27413138 |
92 | Endocytosis_Homo sapiens_hsa04144 | 0.26891078 |
93 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.24935641 |
94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.23495662 |
95 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.23076219 |
96 | Spliceosome_Homo sapiens_hsa03040 | 0.22826195 |
97 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.21217086 |
98 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.20344851 |
99 | Pathways in cancer_Homo sapiens_hsa05200 | 0.19730434 |
100 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.19423566 |
101 | Phagosome_Homo sapiens_hsa04145 | 0.18492753 |
102 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.18398185 |
103 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.18184641 |
104 | RNA degradation_Homo sapiens_hsa03018 | 0.17676640 |
105 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.17400748 |
106 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.16319841 |
107 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.15526567 |
108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.15117659 |
109 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.14585532 |
110 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.14281795 |
111 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.12855935 |
112 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.11007430 |
113 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.10672939 |
114 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.10462233 |
115 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.07894048 |
116 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.05370026 |
117 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.04995397 |
118 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.03344066 |
119 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.00505350 |